Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI
- 1 January 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 342 (2-3) , 153-161
- https://doi.org/10.1016/s0014-2999(97)01494-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.Proceedings of the National Academy of Sciences, 1996
- Regional differences in the effect of haloperidol and atypical neuroleptics on interstitial levels of DOPAC in the rat forebrain: an in vivo microdialysis studyJournal of Psychopharmacology, 1996
- Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptorsNature, 1995
- Pharmacological aspects of R-( + )-7-OH-DPAT, a putative dopamine D3 receptor ligandEuropean Journal of Pharmacology, 1993
- cis-1,2,3a,4,5,9b-Hexahydro-3H-benz[e] indoles: Synthesis and In Vitro Binding Affinity at Dopamine D1 and D2 ReceptorsJournal of Pharmaceutical Sciences, 1993
- Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniquesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Neuroleptic-induced catalepsy: A D2 blockade phenomenon?Pharmacology Biochemistry and Behavior, 1985
- Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor BlockadeActa Pharmacologica et Toxicologica, 1982
- Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of miceEuropean Journal of Pharmacology, 1981
- Dopamine and the Pathophysiology of Dyskinesias Induced by Antipsychotic DrugsAnnual Review of Neuroscience, 1980